XML 38 R23.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Reporting SEGMENT REPORTING
Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the Company’s CODM, or decision making group, whose function is to allocate resources to and assess the performance of the operating segments. The Company has identified its President and Chief Executive Officer as the CODM. In determining its reportable segments, the Company considered the markets and types of customers served and the products or services provided in those markets. The Company has determined that it has one operating segment, and therefore, one reportable segment.
Revenues by geographic regions are based upon the customers’ ship-to address for product revenue, the region of testing for testing services revenue and the region where the performance obligation is satisfied for patient and digital solutions revenue. The following table summarizes reportable revenues by geographic regions (in thousands):
Year Ended December 31,
202420232022
Testing services revenue
United States$248,247 $209,158 $262,959 
Rest of World1,134 527 789 
$249,381 $209,685 $263,748 
Product revenue
United States$26,024 $19,753 $16,409 
Europe10,549 9,901 9,081 
Rest of World4,210 3,863 3,761 
$40,783 $33,517 $29,251 
Patient and digital solutions revenue
United States$43,461 $36,719 $28,175 
Europe120 266 468 
Rest of World40 137 151 
$43,621 $37,122 $28,794 
Total revenue
Total United States$317,732 $265,630 $307,543 
Total Europe$10,669 $10,167 $9,549 
Total Rest of World$5,384 $4,527 $4,701 
$333,785 $280,324 $321,793 
The following table summarizes long-lived assets, consisting of property and equipment, net, by geographic regions (in thousands):
December 31, 2024December 31, 2023
Long-lived assets:
United States$33,286 $34,714 
Europe258 476 
Rest of World8 56 
Total$33,552 $35,246 

The Company’s CODM assessed the Company’s performance by using net income (loss). The CODM uses net income (loss) predominately in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis for the profit measure when making decisions. The CODM organizes the business and leaders functionally. The CODM assesses performance and resources are allocated to functions which utilizes those allocations across the business's services, products and digital solutions offerings.
The following table summarizes the reconciliation to net income (loss) (in thousands):
Year Ended December 31,
202420232022
Revenue:
Testing services revenue
$249,381 $209,685 $263,748 
Product revenue
40,783 33,517 29,251 
Patient and digital revenue
43,621 37,122 28,794 
Total revenue
333,785 280,324 321,793 
Less:
Cost of testing services1
52,734 54,472 69,441 
Cost of product1
20,904 15,672 14,803 
Cost of patient and digital solutions
28,502 23,631 20,011 
Personnel cost116,251 103,354 109,216 
Professional and legal fees
42,655 63,695 60,575 
Research materials and clinical trials expense
14,653 18,277 17,452 
Depreciation and amortization expense
12,455 12,413 9,729 
Stock-based compensation expense
66,406 49,086 46,553 
Litigation expense
(96,300)96,300 — 
Other segment items2
34,741 45,575 54,388 
Interest income, net
(11,765)(11,867)(3,762)
Segment and consolidated net income (loss)
$52,549 $(190,284)$(76,613)

1 Cost of testing services and cost of product include depreciation expense.
2 Other segment items include the following: restructuring costs, acquisition costs, software expenses, corporate expenses, rent and maintenance expense, travel and event related expense, and other expenses (income).